Hochschulschrift
The role of TM6SF2 in the progression of non-alcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
31 cm
- Umfang
-
XIV, 119 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Technische Universität Dresden, Dissertation, 2023
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2023
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease
Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
Non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease
Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
Non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease